DE10304141B4 - Verfahren zur Herstellung von Chinazolin-Alkaloiden - Google Patents
Verfahren zur Herstellung von Chinazolin-Alkaloiden Download PDFInfo
- Publication number
- DE10304141B4 DE10304141B4 DE10304141A DE10304141A DE10304141B4 DE 10304141 B4 DE10304141 B4 DE 10304141B4 DE 10304141 A DE10304141 A DE 10304141A DE 10304141 A DE10304141 A DE 10304141A DE 10304141 B4 DE10304141 B4 DE 10304141B4
- Authority
- DE
- Germany
- Prior art keywords
- compound
- iii
- salt
- reaction
- pyrrolidone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 229930002339 quinazoline alkaloid Natural products 0.000 title claims abstract description 7
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title claims abstract 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 56
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000002425 crystallisation Methods 0.000 claims description 21
- 230000008025 crystallization Effects 0.000 claims description 20
- 239000011541 reaction mixture Substances 0.000 claims description 18
- 150000003839 salts Chemical group 0.000 claims description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 238000006722 reduction reaction Methods 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 11
- 239000013078 crystal Substances 0.000 claims description 11
- 239000002585 base Substances 0.000 claims description 10
- 239000011701 zinc Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- 229960000583 acetic acid Drugs 0.000 claims description 7
- 239000012362 glacial acetic acid Substances 0.000 claims description 7
- 239000007795 chemical reaction product Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 238000007711 solidification Methods 0.000 claims description 4
- 230000008023 solidification Effects 0.000 claims description 4
- 239000012670 alkaline solution Substances 0.000 claims description 3
- 239000012458 free base Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- VARHXCYGZKSOOO-UHFFFAOYSA-N Deoxyvasicinone Natural products C1=CC=C2C(=O)N(CCC3)C3=NC2=C1 VARHXCYGZKSOOO-UHFFFAOYSA-N 0.000 description 57
- WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 description 44
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- VYFOAVADNIHPTR-UHFFFAOYSA-N isatoic anhydride Chemical compound NC1=CC=CC=C1CO VYFOAVADNIHPTR-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000006214 Clemmensen reduction reaction Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- KTCXMTWSISEJFZ-UHFFFAOYSA-N 2,3,4,9-tetrahydro-1h-pyrrolo[2,1-b]quinazolin-10-ium;chloride Chemical compound Cl.C1C2=CC=CC=C2N=C2N1CCC2 KTCXMTWSISEJFZ-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- 238000005292 vacuum distillation Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 150000003246 quinazolines Chemical class 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229910000669 Chrome steel Inorganic materials 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- YIICVSCAKJMMDJ-UHFFFAOYSA-N L-vasicine Natural products C1=CC=C2N=C3C(O)CCN3CC2=C1 YIICVSCAKJMMDJ-UHFFFAOYSA-N 0.000 description 2
- LUMDXNLBIYLTER-UHFFFAOYSA-N Luotonin A Chemical compound C1=CC=C2C(=O)N(CC=3C4=NC5=CC=CC=C5C=3)C4=NC2=C1 LUMDXNLBIYLTER-UHFFFAOYSA-N 0.000 description 2
- YIICVSCAKJMMDJ-SNVBAGLBSA-N Peganine Chemical compound C1=CC=C2N=C3[C@H](O)CCN3CC2=C1 YIICVSCAKJMMDJ-SNVBAGLBSA-N 0.000 description 2
- YIICVSCAKJMMDJ-JTQLQIEISA-N Peganine Natural products C1=CC=C2N=C3[C@@H](O)CCN3CC2=C1 YIICVSCAKJMMDJ-JTQLQIEISA-N 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- -1 phenoxyl group Chemical group 0.000 description 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- IPXZMXGCEORBNJ-UHFFFAOYSA-N 1,2-dihydropyrrolo[3,4-b]quinolin-3-one Chemical compound C1=CC=C2N=C3C(=O)NCC3=CC2=C1 IPXZMXGCEORBNJ-UHFFFAOYSA-N 0.000 description 1
- PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 1
- SYLRFDTUTMLVNM-UHFFFAOYSA-N 4-phenoxybutanoyl chloride Chemical compound ClC(=O)CCCOC1=CC=CC=C1 SYLRFDTUTMLVNM-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 description 1
- 206010057852 Nicotine dependence Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000005523 Peganum harmala Species 0.000 description 1
- 235000005126 Peganum harmala Nutrition 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000025569 Tobacco Use disease Diseases 0.000 description 1
- 241000159213 Zygophyllaceae Species 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Priority Applications (27)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10304141A DE10304141B4 (de) | 2003-02-03 | 2003-02-03 | Verfahren zur Herstellung von Chinazolin-Alkaloiden |
| DK04704202T DK1590351T3 (da) | 2003-02-03 | 2004-01-22 | Fremgangsmåder til fremstilling af chinazolinalkaloider |
| DE502004007980T DE502004007980D1 (de) | 2003-02-03 | 2004-01-22 | Verfahren zur herstellung von chinazolin-alkaloiden |
| UAA200507716A UA81287C2 (en) | 2003-02-03 | 2004-01-22 | Method for producing quinazoline alkaloids |
| MXPA05008179A MXPA05008179A (es) | 2003-02-03 | 2004-01-22 | Procedimiento para la fabricacion de alcaloides de quinazolina. |
| EA200501135A EA009047B1 (ru) | 2003-02-03 | 2004-01-22 | Способы получения алкалоидов хиназолина |
| PT04704202T PT1590351E (pt) | 2003-02-03 | 2004-01-22 | Processos para a produção de alcalóides de quinazolina |
| AT04704202T ATE407135T1 (de) | 2003-02-03 | 2004-01-22 | Verfahren zur herstellung von chinazolin- alkaloiden |
| NZ541101A NZ541101A (en) | 2003-02-03 | 2004-01-22 | Methods for producing quinazoline alkaloids |
| PCT/EP2004/000485 WO2004069836A1 (de) | 2003-02-03 | 2004-01-22 | Verfahren zur herstellung von chinazolin-alkaloiden |
| CA002514945A CA2514945A1 (en) | 2003-02-03 | 2004-01-22 | Methods for producing quinazoline alkaloids |
| ES04704202T ES2314366T3 (es) | 2003-02-03 | 2004-01-22 | Procedimiento para la fabricacion de alcaloides de quinazolina. |
| AU2004208873A AU2004208873B2 (en) | 2003-02-03 | 2004-01-22 | Methods for producing quinazoline alkaloids |
| CNB2004800034182A CN100558727C (zh) | 2003-02-03 | 2004-01-22 | 喹唑啉生物碱类产品的制备方法 |
| KR1020057013954A KR20050096165A (ko) | 2003-02-03 | 2004-01-22 | 퀴나졸린 알칼로이드의 제조 방법 |
| JP2006501573A JP2006516578A (ja) | 2003-02-03 | 2004-01-22 | キナゾリンアルカロイドの製造方法 |
| BR0407012-7A BRPI0407012A (pt) | 2003-02-03 | 2004-01-22 | Processo para a produção de um composto e uso do composto |
| PL378406A PL378406A1 (pl) | 2003-02-03 | 2004-01-22 | Sposób wytwarzania alkaloidów chinazolinowych |
| EP04704202A EP1590351B1 (de) | 2003-02-03 | 2004-01-22 | Verfahren zur herstellung von chinazolin-alkaloiden |
| US10/544,265 US7495096B2 (en) | 2003-02-03 | 2004-01-22 | Processes for the production of chinazoline alkaloids |
| HK05110155.5A HK1075898B (en) | 2003-02-03 | 2004-01-22 | Methods for producing quinazoline alkaloids |
| SI200430943T SI1590351T1 (sl) | 2003-02-03 | 2004-01-22 | Postopki za pripravo kinazolinskih alkaloidov |
| ARP040100246A AR042946A1 (es) | 2003-02-03 | 2004-01-28 | Procedimiento para la fabricacion de alcaloides quinazolina |
| MYPI20040294A MY141734A (en) | 2003-02-03 | 2004-01-30 | Methods for producing quinazoline alkaloids |
| TW093102290A TW200418811A (en) | 2003-02-03 | 2004-02-02 | Processes for the production of chinazoline alkaloids |
| ZA200505160A ZA200505160B (en) | 2003-02-03 | 2005-06-24 | Methods for producing quinazoline alkaloids |
| NO20053689A NO20053689L (no) | 2003-02-03 | 2005-07-29 | Fremgangsmate for fremstilling av quinazolin alkaloider. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10304141A DE10304141B4 (de) | 2003-02-03 | 2003-02-03 | Verfahren zur Herstellung von Chinazolin-Alkaloiden |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE10304141A1 DE10304141A1 (de) | 2004-08-26 |
| DE10304141B4 true DE10304141B4 (de) | 2006-03-09 |
Family
ID=32747532
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE10304141A Expired - Fee Related DE10304141B4 (de) | 2003-02-03 | 2003-02-03 | Verfahren zur Herstellung von Chinazolin-Alkaloiden |
| DE502004007980T Expired - Lifetime DE502004007980D1 (de) | 2003-02-03 | 2004-01-22 | Verfahren zur herstellung von chinazolin-alkaloiden |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE502004007980T Expired - Lifetime DE502004007980D1 (de) | 2003-02-03 | 2004-01-22 | Verfahren zur herstellung von chinazolin-alkaloiden |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7495096B2 (https=) |
| EP (1) | EP1590351B1 (https=) |
| JP (1) | JP2006516578A (https=) |
| KR (1) | KR20050096165A (https=) |
| CN (1) | CN100558727C (https=) |
| AR (1) | AR042946A1 (https=) |
| AT (1) | ATE407135T1 (https=) |
| AU (1) | AU2004208873B2 (https=) |
| BR (1) | BRPI0407012A (https=) |
| CA (1) | CA2514945A1 (https=) |
| DE (2) | DE10304141B4 (https=) |
| DK (1) | DK1590351T3 (https=) |
| EA (1) | EA009047B1 (https=) |
| ES (1) | ES2314366T3 (https=) |
| MX (1) | MXPA05008179A (https=) |
| MY (1) | MY141734A (https=) |
| NO (1) | NO20053689L (https=) |
| NZ (1) | NZ541101A (https=) |
| PL (1) | PL378406A1 (https=) |
| PT (1) | PT1590351E (https=) |
| SI (1) | SI1590351T1 (https=) |
| TW (1) | TW200418811A (https=) |
| UA (1) | UA81287C2 (https=) |
| WO (1) | WO2004069836A1 (https=) |
| ZA (1) | ZA200505160B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004048927A1 (de) * | 2004-10-06 | 2006-04-20 | Lts Lohmann Therapie-Systeme Ag | Pharmazeutische Kombination enthaltend Desoxypeganin und Cyp2D6 Inhibitoren |
| EP3661502A4 (en) | 2017-08-03 | 2020-12-02 | Galectin Sciences, LLC | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF MEDICAL CONDITIONS AND THEIR USES |
| KR102728780B1 (ko) * | 2021-11-30 | 2024-11-08 | 이화여자대학교 산학협력단 | 데옥시바시시논을 유효성분으로 포함하는 미백용 조성물 및 상기 데옥시바시시논 제조방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU605614A1 (ru) * | 1971-10-20 | 1978-05-05 | Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср | Антихолинэстеразное средство |
| JP3180464B2 (ja) * | 1991-08-30 | 2001-06-25 | 新日本理化株式会社 | ジアセタール化合物の製造方法 |
| DE19530606A1 (de) * | 1995-08-21 | 1997-02-27 | Basf Ag | 1-(Pyridyl)-pyrazole |
| JP3958452B2 (ja) * | 1997-10-31 | 2007-08-15 | 大日精化工業株式会社 | 新規化学発光試薬及びその製造方法 |
| DE19906975B4 (de) | 1999-02-19 | 2004-04-15 | Lts Lohmann Therapie-Systeme Ag | Arzneiform zur Behandlung von Alzheimer'scher Demenz |
| DE19906979B4 (de) | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
| DE19906978B4 (de) | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit |
-
2003
- 2003-02-03 DE DE10304141A patent/DE10304141B4/de not_active Expired - Fee Related
-
2004
- 2004-01-22 DK DK04704202T patent/DK1590351T3/da active
- 2004-01-22 DE DE502004007980T patent/DE502004007980D1/de not_active Expired - Lifetime
- 2004-01-22 EA EA200501135A patent/EA009047B1/ru not_active IP Right Cessation
- 2004-01-22 AT AT04704202T patent/ATE407135T1/de active
- 2004-01-22 KR KR1020057013954A patent/KR20050096165A/ko not_active Ceased
- 2004-01-22 AU AU2004208873A patent/AU2004208873B2/en not_active Ceased
- 2004-01-22 WO PCT/EP2004/000485 patent/WO2004069836A1/de not_active Ceased
- 2004-01-22 US US10/544,265 patent/US7495096B2/en not_active Expired - Fee Related
- 2004-01-22 CN CNB2004800034182A patent/CN100558727C/zh not_active Expired - Fee Related
- 2004-01-22 ES ES04704202T patent/ES2314366T3/es not_active Expired - Lifetime
- 2004-01-22 NZ NZ541101A patent/NZ541101A/en not_active IP Right Cessation
- 2004-01-22 PL PL378406A patent/PL378406A1/pl not_active Application Discontinuation
- 2004-01-22 BR BR0407012-7A patent/BRPI0407012A/pt not_active Application Discontinuation
- 2004-01-22 JP JP2006501573A patent/JP2006516578A/ja active Pending
- 2004-01-22 EP EP04704202A patent/EP1590351B1/de not_active Expired - Lifetime
- 2004-01-22 CA CA002514945A patent/CA2514945A1/en not_active Abandoned
- 2004-01-22 MX MXPA05008179A patent/MXPA05008179A/es active IP Right Grant
- 2004-01-22 SI SI200430943T patent/SI1590351T1/sl unknown
- 2004-01-22 UA UAA200507716A patent/UA81287C2/uk unknown
- 2004-01-22 PT PT04704202T patent/PT1590351E/pt unknown
- 2004-01-28 AR ARP040100246A patent/AR042946A1/es unknown
- 2004-01-30 MY MYPI20040294A patent/MY141734A/en unknown
- 2004-02-02 TW TW093102290A patent/TW200418811A/zh unknown
-
2005
- 2005-06-24 ZA ZA200505160A patent/ZA200505160B/en unknown
- 2005-07-29 NO NO20053689A patent/NO20053689L/no not_active Application Discontinuation
Non-Patent Citations (1)
| Title |
|---|
| J.S. Yadav, B.V.S. Reddy, Tetrah. Lett. 43 (2002) 1905 * |
Also Published As
| Publication number | Publication date |
|---|---|
| PL378406A1 (pl) | 2006-04-03 |
| EA009047B1 (ru) | 2007-10-26 |
| MXPA05008179A (es) | 2006-02-17 |
| MY141734A (en) | 2010-06-15 |
| AU2004208873B2 (en) | 2009-12-17 |
| HK1075898A1 (zh) | 2005-12-30 |
| DE502004007980D1 (de) | 2008-10-16 |
| ZA200505160B (en) | 2007-01-31 |
| CA2514945A1 (en) | 2004-08-19 |
| US7495096B2 (en) | 2009-02-24 |
| KR20050096165A (ko) | 2005-10-05 |
| UA81287C2 (en) | 2007-12-25 |
| EP1590351B1 (de) | 2008-09-03 |
| EA200501135A1 (ru) | 2006-02-24 |
| ES2314366T3 (es) | 2009-03-16 |
| AU2004208873A1 (en) | 2004-08-19 |
| WO2004069836A1 (de) | 2004-08-19 |
| US20060084669A1 (en) | 2006-04-20 |
| BRPI0407012A (pt) | 2006-01-10 |
| DK1590351T3 (da) | 2008-12-15 |
| PT1590351E (pt) | 2008-11-21 |
| CN100558727C (zh) | 2009-11-11 |
| JP2006516578A (ja) | 2006-07-06 |
| AR042946A1 (es) | 2005-07-06 |
| TW200418811A (en) | 2004-10-01 |
| DE10304141A1 (de) | 2004-08-26 |
| EP1590351A1 (de) | 2005-11-02 |
| NZ541101A (en) | 2009-03-31 |
| SI1590351T1 (sl) | 2009-02-28 |
| ATE407135T1 (de) | 2008-09-15 |
| NO20053689L (no) | 2005-07-29 |
| CN1745084A (zh) | 2006-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2445862B1 (de) | Herstellung von substituierten 2-fluoracrylsäurederivaten | |
| DE2717549A1 (de) | Pyrazolo eckige klammer auf 4,3-e eckige klammer zu eckige klammer auf 1,2,4 eckige klammer zu triazolo eckige klammer auf 4,3-c eckige klammer zu pyrimidine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE1670772A1 (de) | Verfahren zur Herstellung von Benzoxazin-Derivaten | |
| DE1795832C3 (de) | O-Aminoarylketimine und Verfahren zu ihrer Herstellung | |
| DD140040A5 (de) | Verfahren zur herstellung von 5-alkylthio-pyrimidinen | |
| DE2519480A1 (de) | Aryl-oxo-heptensaeuren | |
| DE1695929C3 (de) | 1 ^-Dihydro-1 -hydroxy^-imino^-amino-6-methylpyrimidine sowie ein Verfahren zu deren Herstellung | |
| DE10304141B4 (de) | Verfahren zur Herstellung von Chinazolin-Alkaloiden | |
| EP0225522A1 (de) | Imidazopyridazinalkensäureamide, Verfahren ihrer Herstellung, Zwischenprodukte zu ihrer Herstellung | |
| DE69707860T2 (de) | Verfahren zur herstellung von tetrahydroindolizinen | |
| DE2841644C2 (https=) | ||
| DE2633931A1 (de) | Pyrazolderivate, deren salze mit saeuren, verfahren zu ihrer herstellung und arzneipraeparate | |
| EP0653423B1 (de) | Verfahren zur Herstellung von substituierten Chinazolin-2,4-dionen | |
| DE2943286C2 (https=) | ||
| DE1935404B2 (de) | Verfahren zur Herstellung von Chinazolinonen | |
| CH646971A5 (de) | Dihalogen-substituierte anelierte pyrimidin-4-on-derivate und verfahren zu ihrer herstellung. | |
| DE60000560T2 (de) | Verfahren zur Herstellung einer sehr sauberen Phenotiazin Verbindung | |
| DE3236096A1 (de) | In der 7- oder 8-stellung chlor- oder trifluormethylsubstituierte n-(chinol-4-yl)-anthranilsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE3028291C2 (de) | 3-Methylbenzo[b]furyl-2-acetamide und diese Verbindungen enthaltende Arzneimittel | |
| EP0423595B1 (de) | Verfahren zur Herstellung von 3-Trichlormethyl-pyridin | |
| DE2302970A1 (de) | Verfahren zur herstellung heterocyclischer verbindungen | |
| DE2148959C3 (de) | Verfahren zur Herstellung N-substituierter 4-Anilinopiperidine | |
| DE3932136C1 (https=) | ||
| DE2539504A1 (de) | Pyrido eckige klammer auf 3,4-d eckige klammer zu pyridazine und verfahren zu ihrer herstellung | |
| EP0150411A1 (de) | Verfahren zur Herstellung substituierter Chinazolin-2.4(1H.3H)-dione |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| 8364 | No opposition during term of opposition | ||
| R119 | Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee |
Effective date: 20120901 |